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Abstract 
 
Background Fetal macrosomia occurs in approximately 10% of all pregnancies taking place in 
the United States. Babies born LGA are placed at a greater risk for shoulder dystocia, perinatal 
trauma, cesarean section, jaundice, hypoglycemia, and neonatal intensive care admission. Even 
more, the long-term impacts are severe and include increased risk of becoming overweight or 
obese and developing type 2 diabetes later in life. Women with gestational diabetes mellitus 
(GDM) have higher rates of delivering macrosomic offspring due to insulin resistance taking 
place beyond what is normal during a pregnancy. Additionally, maternal obesity, socioeconomic 
status, and race/ethnicity have been associated with maternal and fetal risk during pregnancy.  
 
Objectives This study sought to ascertain the role that race/ethnicity, income level, and pre-
pregnancy BMI has on the risk for delivering a LGA infant when women are diagnosed with 
gestational diabetes mellitus.  
 
Subjects Women diagnosed with gestational diabetes mellitus that gave birth at Spectrum Health 
Butterworth Hospital between January 1, 2010 and December 31, 2016.  
 
Methods Eligible participants’ age, race/ethnicity, form of insurance, zip code, pre-pregnancy 
BMI, diagnosis of LGA/macrosomia, shoulder dystocia, and form of delivery were obtained 
through retrospective chart reviews to investigate the association of interest. Zip codes were 
utilized to create rounded estimated household incomes based on census data.  
 
Analyses Means ± standard deviations were used to describe continuous characteristics and 
frequencies were used to describe discrete characteristics in this sample. Cross tabulations and 
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confidence intervals of proportions were used to determine any significant relationship among or 
within the categorical variables. Logistic regression was performed to estimate the odds of 
delivering a LGA or macrosomic newborn using demographic characteristics of the mother.  
 
Results The overall prevalence of macrosomia in this patient population was 11.8%. Rates of 
shoulder dystocia were significantly higher in babies born LGA when compared to those born of 
normal or smaller size in this cohort. When age, pre-pregnancy BMI, race/ethnicity, and annual 
income were considered together in a logistic regression model, the odds of delivering a LGA 
baby was 10.7 times greater for those with Medicaid/Medicare. This study also discovered a 
decreased likelihood of African American and Hispanic women of having a large baby when 
compared to Caucasian women.  
 
Conclusion Shoulder dystocia takes place more often in babies born LGA than those that were 
of normal or smaller size. Women with government funded health insurance are at an increased 
likelihood of having an LGA baby, while Hispanic and African American race/ethnicity places 
women at a decreased likelihood. Future studies are warranted to identify the existence and 
extent of confounding variables. Additionally, more research is needed on the social 
determinants of health, including prenatal care adequacy, paternal race/ethnicity, social support, 
and WIC participation. 
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Introduction 
 
Large-for-gestational age (LGA) is defined as a birth weight greater than the 90th 
percentile for age based on gestation. Using a national reference based on single live births in the 
United States, infants born at 40 weeks’ gestation at the 90th percentile would have a birth weight 
equal to or greater than 4000 grams.1 Fetal macrosomia is commonly used as a synonym for 
LGA and is defined as a birth weight greater than 4,000 grams irrespective of gestational age.2 
Macrosomia occurs in more than 10% of all pregnancies in the United States.3 These births are 
correlated with major problems during labor including shoulder dystocia, perinatal trauma, 
cesarean section, and admission to neonatal intensive care units.4 Additionally, LGA infants 
experience an increased long-term risk of becoming overweight or obese and developing type 2 
diabetes later in life.5,6 
                It is estimated that 12% of newborns to normoglycemic women and 15-45% of 
newborns of women with gestational diabetes mellitus (GDM) are born LGA.7 The increased 
risk in mothers with GDM can be attributed to the insulin resistance of the mother beyond what 
normally takes place during pregnancy.  The exacerbated insulin resistance leads to a persistent 
hyperglycemic state. In GDM, higher levels of blood glucose pass through the placenta into fetal 
circulation. From the second trimester onwards, the fetal pancreas responds by increasing their 
secretion of insulin, resulting in hyperinsulinemia.7 Together, the hyperinsulinemia and 
hyperglycemia result in higher fat and protein stores and thereby, accelerated fetal growth.8 
In addition to maternal hyperglycemia, maternal obesity has a strong but independent 
effect on fetal macrosomia.9 Several previous studies have shown that high pre-pregnancy BMI 
may be associated with increased risks of maternal and neonatal outcomes including gestational 
diabetes mellitus (GDM), hypertensive disorders in pregnancy, cesarean delivery, large for 
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gestational age infant (LGA), and macrosomia.10,11 In one systematic review and meta-analysis, it 
was found that the odds of delivering a large for gestational age infant are increased by 142% for 
obese mothers.12 
                Socioeconomic disparities in birth weights (BWs) are associated with lifelong 
differences in health and productivity.13 Several studies have provided evidence that the 
prevalence of infants born preterm and small-for-gestational age (SGA) decreases with higher 
socioeconomic status reflected by income, education, and employment status.14 Many of these 
studies do not include LGA infants in their analysis, however and thus, need further exploration.  
In addition to socioeconomic status, racial/ethnic disparities in birth outcomes are widely 
researched and their findings documented. Non-Hispanic Black women exhibit the highest risks 
of low birth weight, preterm delivery, and infant mortality.15 A recent study demonstrated that 
infants of Non-Hispanic Black, Hispanic and Asian women had risks of adverse birth outcomes 
between 10% and 210% greater than Non-Hispanic White women.16  
While the fetal and maternal risks associated with infants born LGA are well established, 
gaps remain in the literature on the prevalence among sub-groups of women at high risk of 
adverse birth outcomes. This proposed study seeks to ascertain the role race/ethnicity, income 
level and pre-pregnancy BMI have on the risk of LGA infants born to women with GDM.  
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Literature Review 
Large-for-gestational age & Related Complications 
LGA birth and its associated complications during labor and delivery are the most 
frequent and serious forms of morbidity for infants to women with GDM. Macrosomic fetuses in 
diabetic pregnancies acquire central deposition of subcutaneous fat in both the abdominal and 
interscapular areas. This results in larger shoulder and extremity circumferences, and a decreased 
head-to-shoulder ratio. Significantly higher body fat and thicker upper-extremity skinfolds are 
also characteristic of these infants. However, because fetal head size does not increase, shoulder 
and abdominal girth can become augmented, making vaginal birth risks more common.7  
If the baby becomes wedged in the birth canal, labor may take more time and 
instrumental delivery may be necessary. As such, unplanned or emergency cesarean section are 
sometimes required. Mothers delivering LGA infants are at a greater risk for laceration of the 
vaginal tissue as well as perineal tears. Larger than normal babies can also lead to uterine atony, 
where the uterus muscle does not contract appropriately, thereby causing heavy bleeding.7  
The risks of a LGA birth are not limited to the mother as many fetal risks can present too. 
One of the most serious problems of vaginal deliveries is shoulder dystocia. It occurs when the 
fetal shoulders do not deliver after the head has emerged from the vaginal canal. One or both 
shoulders becomes impacted against the bones of the maternal pelvis. Shoulder dystocia is 
considered an obstetric emergency, and can lead to fetal death if the infant is not delivered 
expediently.17  
In a 2013 study conducted by Ouzounian et al, 221 cases of shoulder dystocia from a 
cohort of 13,277 vaginal deliveries were assessed and demonstrated that more than half (50.7%) 
took place in the delivery of LGA infants.18 Furthermore, when compared side by side, infants of 
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diabetic mothers (both gestational and pre-gestational) have an increased risk of shoulder 
dystocia even with normal birthweight. The authors proposed that this could be due to the 
potential dysmorphic features including thicker upper extremity skinfolds, higher body fat, and 
broader shoulders often seen in these babies.18  
Macrosomia is also associated with excessive rates of neonatal morbidity. Macrosomic 
neonates have higher rates of both  hypoglycemia and neonatal jaundice when compared to the 
infants of mothers without diabetes.7  A retrospective cohort study of women with type 2 
diabetes or GDM and their singleton neonates found that the incidence of neonatal hypoglycemia 
was 18% and was statistically associated with birth weight and macrosomia.19 Neonate 
hypoglycemia occurs as a result of the hyperinsulinemia in utero as a response to the high blood 
glucose levels from the mother. While less common, it can lead to serious complications 
including central nervous system and cardiopulmonary disorders.  
Gestational Diabetes Mellitus  
A recent study by Desisto et al. indicated that GDM prevalence is as high as 9.2% in the 
United States, the highest prevalence observed in the world.20  Furthermore, these rates have 
increased with the steady rise of obesity and type 2 diabetes.20,21 A recent study collecting 
hospital discharge data from 1994 to 2004 found that rates of GDM increased by 56% in the ten-
year time frame.22  In the United States, rates of GDM are highest in Asian, non-Hispanic black, 
Native American, and Hispanic women and lowest in Non-Hispanic white women.23 
Risk factors associated with GDM include pre-pregnancy overweight or obesity, 
advanced maternal age, being from various minority race/ethnicity groups, multipara, and GDM 
in the previous pregnancy.24,25 Interestingly, a history of GDM is one of the most reliable risk 
factors concerning the development of type 2 diabetes for the mother later on.26  
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Gestational diabetes mellitus is defined as glucose intolerance with an onset or diagnosis 
taking place during pregnancy.27 In a recent study evaluating 7,415 diabetic and non-diabetic 
mothers, the rate of LGA among DM and non-DM was 23.7% and 10.5%, respectively.28 The 
exact mechanisms behind GDM are unclear, however, the maternal and fetal-placental factors’ 
interaction have been studied at length.27, 29 
The placenta size increases as gestational age advances and with it, there is a rise in level 
of estrogen, progesterone, cortisol, and placental lactogen in the maternal blood supply. 
Beginning at 20 to 24 weeks of gestation, this is accompanied by an increase in insulin resistance 
that approximate the insulin resistance observed in people with type 2 diabetics. When the 
mother delivers the fetus, the placental hormone production stops and the insulin resistance 
abates.30 This observation strongly suggests that these hormones dictate the difference in insulin 
resistance compared to what takes place in a healthy pregnancy.  
Human placental lactogen increases 10-fold during the second half of pregnancy and 
stimulates lipolysis. This causes the mother to use free fatty acids as an alternative fuel source, 
thereby conserving glucose and amino acids for the fetus. In turn, the mobilization of free fatty 
acids interferes with the insulin-directed entry of glucose into cells. For this reason, human 
placental lactogen is considered an antagonist of insulin action during pregnancy.7  
Pedersen’s hypothesis is used to explain the pathophysiology of LGA infants. This 
hypothesis is based on the fact that glucose, when elevated, crosses the placenta. The maternal-
derived insulin, however cannot. Consequently, in the second trimester, the fetal pancreas which 
has developed to secrete insulin, responds to high blood glucose.  Even more, it does so in an 
automated manner, regardless of glucose stimulation leading to hyperinsulinemia. This 
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combination of hyperinsulinemia and hyperglycemia causes glucose to be stored as adipose and 
protein tissue.7 
Adipose tissue also plays a role in the development of GDM. This tissue produces 
adipocytokines, including leptin, adiponectin, tumor necrosis factor, and interleukin-6, as well as 
resistin, visfatin, and apelin.31,32 Adipocytokines and elevated lipid concentrations have been 
associated with insulin resistance in both pregnant and non-pregnant women. Evidence suggests 
that one or more of these components may impair insulin signaling.33  
Data from the 1991 Diabetes in Early Pregnancy Study discovered that fetal birth weight 
is most closely correlated with second and third-trimester postprandial blood sugar levels. This 
study found that when postprandial glucose values average 120 mg/dl or less, approximately 
20% of infants can be expected to be born LGA. Furthermore, if the glucose values are as high as 
160 mg/dl, the rate can reach up to 35%.34 In another study evaluating the Mediterranean 
population, the adjusted odds ratio associated with one standard deviation increase (7 mg/dL) in 
the fasting plasma glucose was 1.26 for LGA infants.35 If a woman had a fasting glucose of 157 
mg/dL, her odds of having an LGA infant would be 1.26 times greater than that of a woman with 
a fasting glucose of 150 mg/dL. Even more, a prospective mother-offspring multiethnic cohort 
study of 1247 mothers (57.2% Chinese, 25.5% Malay, 17.3% Indian) discovered that with each 
standard deviation increase in fasting glucose, there was a 1.64 increased odds ratio for LGA.36  
Diagnosis of GDM  
Diagnosis of GDM was first proposed in 1964 to be an assay of whole blood glucose 
during a 3-hour oral glucose tolerance test (OGTT). Glucose levels of 90, 165, 145, and 125 
mg/dl for fasting, one-hour, two-hour and three-hour post glucose load respectively, were 
proposed for the diagnostic thresholds. Adjustments have been made over the years based on 
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data from women who were diagnosed with diabetes after gestation.37 Spectrum Health system 
uses the American Diabetes Association (ADA) recommended diagnostic criteria. In this criteria, 
diagnosis is made if two or more of the venous plasma concentrations are met or exceeded. 
These are 95, 180, 155, 140 mg/dL for fasting, one hour, two hour, and three hour fasting, 
respectively.38  
In its’ most recent position statement, the ADA suggested that all pregnant women be 
screened for GDM between the 24th and 28th week of gestation, unless they are low risk. Low 
risk women include those that are younger than 25, normal pre-gestational weight, member of an 
ethnic group with low prevalence of diabetes, have no history of glucose intolerance and poor 
obstetrical outcomes, and no known diabetes in first degree relatives.37  
Pre-Pregnancy BMI and Risk of LGA infants   
One in three adults in the U.S. are obese so it is not surprising that obesity is becoming 
the most common complication of pregnancy and the predominant risk factor for maternal 
mortality in developed countries. Women who are obese prior to pregnancy may suffer poor 
health before, during, and after pregnancy which may affect their birth outcomes as well as their 
willingness or ability to breastfeed.39  
One explanation for the link between birth weight outcomes and maternal weight is the 
fetal origins hypothesis, similar to the Pedersen hypothesis formulated in 1954. The fetal origins 
hypothesis posits that pre-pregnancy obesity causes greater concentrations of glucose and fatty 
acids to be delivered to the developing fetus. The resulting increase in fetal insulin accelerates 
fetal growth and leads to high birth weight. Consistent with this hypothesis, it has been shown 
that women who are overweight or obese at the start of their pregnancy are at increased risks for 
LGA infant and macrosomia.39  
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In one Chinese study, the odds of delivery of LGA for overweight or obese pregnant 
women were 2 and 3.8 times greater than normal weight women, respectively.40 In another study, 
researchers analyzed data for 276, 436 deliveries in 23 developing countries throughout the 
world. Higher maternal age (20-34 years), body-mass index, and presence of diabetes were 
associated with significantly increased risk of macrosomia. In all regions, maternal BMI of 35 
kg/m2 or greater had substantially higher odds for delivering a macrosomic infant than did those 
with a BMI less than 30 kg/m2.41 The results of these studies suggest that primary prevention of 
overweight/obesity in women of childbearing age may be an important strategy to reduce the 
number of LGA newborns, and consequently, the long-term public health burden of obesity.  
Role of Sociodemographic & Socioeconomic Factors on Prenatal Risk  
There is a large body of evidence illustrating the link between socioeconomic status and 
birth risk. Socioeconomic disparities in birth outcomes are pervasive and take place at both the 
individual and community level. A prospective cohort study in Canada used information from 
maternal questionnaires and medical records and found significant associations between lower 
socioeconomic status and increased risk of macrosomia with higher pre-pregnancy BMI at both 
the individual and neighborhood level. The neighborhoods were distinguished by census data 
and closely resemble U.S. zip codes.42 Another study using data for 28,722 live births in 
Shaanxi, China from 2010-2013 discovered that rates of LGA were higher in those of low 
socioeconomic status.43  
While countless studies have examined the association between low socioeconomic status 
and low birth weight, preterm deliveries, and infant death is extensive, there lacks an analysis of 
low-socioeconomic status and risk of delivering an LGA infant.  
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Race/Ethnicity & Poor Outcomes 
To explain the disparities that exist in birth outcomes using the weathering hypothesis 
proposal of cumulative experiences of social inequality and racism, studies have suggested that 
chronic stress associated with everyday interpersonal and institutional racism may have an 
impact on birth outcomes of minorities. Recent data has showed that non-Hispanic Black and 
Hispanic women experience the highest likelihood of having a low birth weight (LBW) or 
preterm infant. These groups of women also have the highest rates of infant and maternal 
mortality.16  
Unfortunately, few studies have evaluated if risk of LGA infants to women with GDM 
varies by race/ethnicity or by income level. Studying such disparities is important from a public 
health standpoint to develop individualized approaches for managing GDM. In doing so, risks to 
mothers and their infants could both be improved.  
 As previously mentioned, incidence of GDM is highest in Asian and non-black Hispanic 
women and lowest in African American and white women.23 These disparities are surprising 
given that obesity, the strongest known risk factor for GDM, is highest in African Americans and 
lowest in Asians.44  
There remains conflicting research on the racial and ethnic disparities in risk for 
macrosomia to women with GDM. A retrospective cohort study found that among Hawaiian 
women with GDM, the highest prevalence of macrosomia was in white women (14.5%), while 
the lowest was in Filipina women (5.3%).45 Another study evaluating a wider range of 
racial/ethnic groups found that the highest risk of LGA were infants born to non-Hispanic black 
women (17.2%), followed by those to Pacific Islander (16.2%), Hispanic (14.5%), non-Hispanic 
 17 
white (13.1%), Asian Indian (12.8%), Filipino (11.6%), and other Asian (9.6-11.1%) women.46 
These findings were consistent with another California study that demonstrated highest rates of 
LGA newborns to African American women (25.1%), lowest rates in Asian women (13.9%), and 
intermediate among Hispanic (17.9%), white (16.4%), and Filipina women (15.3%).47 In most 
racial and ethnic groups, the highest increased risk of LGA newborns was to women with class II 
obesity. Furthermore, African American and Asian women in that BMI category had a four-fold 
increased risk of LGA newborns compared to women in the same racial and ethnic group but of 
normal weight.47  
Contrary to these findings, a 2017 retrospective cohort analysis of births in Texas 
between 2006 and 2011 found that the risk of GDM increased as BMI increased for all 
racial/ethnic groups but that the rate of LGA was lowest in the non-Hispanic Blacks and Asians 
compared to Whites and Hispanics.48 
These studies suggest that the perinatal outcomes in women with GDM differ by 
race/ethnic group. Together, they demonstrate the need for additional research so further 
evidence can support the identification of different counseling techniques for women.  Because 
being overweight and obese are risk factors for both developing gestational diabetes mellitus as 
well as independently for having an infant born LGA, it is likely the rates of both will increase.  
Even more, the increased rate of GDM and LGA will likely draw the attention of health care 
practitioners, thereby requiring uniform diagnostic measures. In addressing the role of 
race/ethnicity and socioeconomic status on the risk of LGA infants born to women diagnosed 
with GDM, this study could better direct public health interventions.  Because the health of 
mothers and their infants is indicative of the future health of communities, it is crucial that the 
health care system understand the disparities at play. 
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Methods and Materials 
Design 
This study was a retrospective chart review. 
 
Subject Selection 
 
The researcher completed a retrospective chart review of 754 women using electronic medical 
records (EMR). These records were selected for study from a large Midwest urban hospital for 
dates of service between January 1, 2010 to December 31, 2016. Following chart selection, the 
researcher used an Honest Broker System to de-identify and enter relevant data into a password 
protected Excel Extraction Tool Spreadsheet. All identifiable data were stored on a secure drive 
only accessible at the healthcare organization. Statistical analysis was completed in October 
2017.  
Inclusion criteria 
Mothers with an ICD 9/10 codes for Gestational diabetes mellitus (Code: O24.41, O24.41, 
O24.410, O24.410, O24.414, O24.414, O24.415, O24.419, O24.419, 648.0, 648.00, 648.00, 
648.01, 648.01, 648.03, 648.03, 648.03) using the hospital’s electronic medical record database 
were included in this study. Of these women, those with infants diagnosed with LGA (ICD-9/10 
Code:656.601, 036.60X0, 036.63X0, O66.2) or macrosomia (ICD-9/10 Code: 766.0, 766.1, 
P08.0, P08.1) were identified. Participants were selected with the following criteria: Pregnant 
women with Gestational diabetes mellitus diagnosis taking place during their pregnancy. 
Exclusion criteria  
Exclusion criteria included any mothers younger than 18 years of age at delivery, any births that 
did not result in a live birth, and any multifetal pregnancies. Due to the study design, consent for 
participation was not necessary and participants were not compensated. 
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Sample Size: Statistical Considerations 
 
Necessary minimum sample size was calculated using An Introduction to Categorical Data 
Analysis textbook by Agresti, 1996. Within the text, a logistic regression calculation was found 
to calculate sample size based off prior research. A probability of having a LGA baby was 
derived from the prior research using 0.16, a power of 0.90, alpha of 0.05, three predictors in the 
model and a correlation estimate of 0.50 for the variables within the model. This calculated to an 
estimation of 825 patients. The sample size available from the designated hospital between 2010-
2016 was 754.  
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Figure 1. Sample Size Determination 
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Data Management 
Data detailing the mother’s age at delivery, race and ethnicity as well as pre-pregnancy BMI 
were collected from the medical record. Race and ethnicity was stratified into four groups: 
Caucasian, African American, Hispanic and Other. Pre-pregnancy BMI was calculated by pre-
pregnancy weight (kg) divided by height (m^2). The BMI categories were based on the World 
Health Organization International Classification of adult underweight, overweight, and obesity 
according to BMI. 
 Underweight: <18.5, 
 Normal: 18.5-24.99 
 Overweight: 25-29.99 
 Obese Class I:30-34.99 
 Obese Class II:35-29.99 
 Obese Class III:>/= 40 
Additionally, the mother’s primary, secondary, and tertiary insurance form were collected as a 
means to represent socioeconomic status. Both median and average income were estimated using 
the mother’s zip code and census data. The offspring’s medical charts were evaluated for LGA 
and macrosomia diagnoses as well as diagnosis of shoulder dystocia. Form of delivery (i.e, 
vaginal versus cesarean section) was also recorded. The table below (Table 1) highlights the data 
descriptions.  
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Table 1: Data Description 
Variable Description Formats 
Record ID Randomly Assigned Record 
ID that goes from 1-754 
 
Diagnosis Year This is the year that the 
Diagnosis of Gestation 
Diabetes Occurred 
 
Delivery Year This is the year the mother 
delivered the baby 
 
Age Age of the mother at delivery  
Racial/Ethnic Group Race/ethnicity of the mother 1=White, 2= Black or African 
American, 3= Hispanic, 
4=Other 
Primary Insurance Group Primary Insurance of the 
Mother at delivery  
0=NA, 
1=Commerical/Private, 
2=Medicare, 3=Medicaid 
Median Income Rounded Median income rounded up 
and comes from the zip code 
of the Mother at delivery and 
cross referenced with census 
estimates 
 
Median Income Group Grouping created based off 
the rounded Median income 
1=<40,000, 2=40,000-45,000, 
3=46,000-49,000, 4=50,000-
59,000 
Average Income Rounded Average Income rounded up 
and comes from the zip code 
of the mother at delivery and 
cross referenced with census 
estimates 
 
Average Income Group Grouping created based off 
the rounded Average Income 
1=<50,000, 2=50,000-55,000, 
3=56,000-65,000, 4=66,000-
75,000, 5=76,000+ 
Macrosomia If baby or Mother had 
LGA/Macrosomia diagnosis 
codes on their records 
0=No, 1=Yes 
Shoulder Dystocia If Mother had a Shoulder 
Dystocia diagnosis code on 
their record 
0=No, 1=Yes 
Cesarean Section Surgical procedure listed as 
Cesarean Section 
0=No, 1=Yes 
BMI Result Year Result of the BMI year  
BMI Pre-pregnancy BMI value  
Days Prior to Delivery Number of days prior to 
delivery that the pre-
pregnancy BMI was captured 
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Statistical Analysis 
Statistical analysis of de-identified data was performed by the researcher with the help of 
members of the Statistics Consulting Center at Grand Valley State University. Data was analyzed 
with SPSS 20. Descriptive/summary statistics were obtained for all data collected. Quantitative 
data was expressed as a means +/- standard deviation and qualitative data is expressed as a 
frequency (percentage). Cross-tabulations were used along with confidence intervals of 
proportions with 95% confidence intervals for all categorical variables. Binary logistic regression 
was used to estimate the odds of delivering an LGA or macrosomic newborn using demographic 
characteristics of the mother. Significance was assessed at the 0.05 level.  
Ethical Considerations 
Institutional review and approval 
To ensure that the basic rights and welfare of the research participants are protected, the protocol 
for this study was submitted to the Spectrum Research Review Committee online, for evaluation 
and approval. They determined that this study is not considered to be human research because it 
does not meet the definition of human subjects as defined by DHHS or FDA regulations. A 
waiver of HIPAA authorization was made.  
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Results 
Of the 754 charts selected by a diagnosis of Gestational diabetes mellitus during 
pregnancy, 89 women delivered a baby described by LGA or macrosomia (11.8%). The form of 
delivery was denoted as a cesarean section in 341 cases (45.2%) compared to 413 women 
(54.8%) that delivered their babies vaginally. Shoulder dystocia occurred in just 12 of the total 
number of deliveries (1.6%). Compared to offspring that did not have the complication of 
shoulder dystocia, those that did were more likely to have been born LGA in that pregnancy 
(33%, CI 0.13-0.60).  
The mothers’ ages ranged from 19 to 50 years of age, with a mean age of 31.15 years (+/- 
5.739 years). There was no significant difference in the risk of macrosomia by age group, with 
all groups experiencing macrosomia rates of approximately 10%. The patients’ race/ethnicity 
was categorized into one of four groups: Caucasian, African American, Hispanic, and Other. 
Hispanic mothers had the highest rates of LGA, however, this was not significantly greater than 
the rates of the other groupings.  In fact, there was no significant difference between any of the 
race/ethnic categories. Additionally, there remained no significant difference in risk by race 
when the women were grouped into non-Caucasian and Caucasian descriptions.  
Average household income determined by the zip code of the mother using Census data 
varied widely, with a minimum of $27,000 and a maximum of $167,000. The mean income was 
$61,980.11 (+/- $16,177.82). Primary insurance form was also reviewed as an indicator for 
socioeconomic status. The majority of study participants received their insurance through 
commercial/employer based insurance (89%). Rates of macrosomia were similar in the 
commercial and government funded insurance groups at 11% and 13%, respectively. Regardless, 
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neither average income nor form of insurance as proxies demonstrated significantly different 
rates of LGA deliveries. 
Pre-pregnancy BMI was only gathered from 142 mothers. The average BMI from this 
sample size was 34.42 (+/- 8.9). Only 8.5% of the women with pre-pregnancy BMI values 
gathered were of normal weight, whereas 23.9% of mothers were overweight, and 66.9% were 
obese. Although the rate of macrosomia was highest among normal weight mothers at 25%, there 
was also no difference in macrosomia risk by pre-pregnancy BMI. See Table 2 for complete 
results of the analyses by maternal characteristics and macrosomia.  
Finally, binary logistic regression was performed as a means to approximate the role of 
maternal demographics on one’s risk for having a baby born LGA.  The results indicate that 
Medicare/Medicaid insurance forms produced the greatest odds ratio (10.7, 95% CI 1.7-68). This 
signifies that women having Medicare/Medicaid insurance in this study were placed at a 10.7 
times greater odds of delivering an infant that was large when compared to women with 
commercial insurance.  
When age, insurance form, average income, and pre-pregnancy BMI were adjusted for, 
African American and Hispanic women experienced a reduced likelihood of macrosomia.  
African American and Hispanic women were at a 16.7 and 20 times lower risk compared to the 
referent group denoted as Caucasian mothers (0.06 95% CI .01-.80, 0.05 95% CI .01-.75). See 
Table 3 for complete results of the logistic regression model.  
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Table 2. Percent of births by macrosomia and maternal and health-related factors, 2010-2016.  
Total Births N=754 Births  
n (%) 
Macrosomia/LGA  
% (95% CI*) 
Maternal age (n=754) 
     25 or under 
     26-30 
     31-36 
     37 or above 
 
142 (19) 
193 (26) 
278 (37) 
141 (19) 
 
10 [.06-.17] 
10 [.06-.15] 
14 [.10-.18] 
10 [.06-.16] 
Maternal race/ethnicity (n=754) 
     Caucasian 
     African American 
     Hispanic 
     Other 
 
460 (61) 
114 (15) 
124 (16) 
56 (7) 
 
12 [.10-.16] 
7 [.03-.13] 
15 [.09-.21] 
7 [.02-.17] 
Maternal BMI (n=142) 
     Underweight 
     Normal 
     Overweight/Obese 
 
1 (1) 
12 (9) 
129 (91) 
 
0 [.00-0.79] 
25 [.08-.53] 
14 [.09-.21]  
Average Income Group (n=754) 
     Less than $50,000 
     $50-55,000 
     $56-65,000 
     $66-75,000 
     $76,000 or greater  
 
37 (18) 
204 (27) 
193 (26) 
99 (13) 
121 (16) 
 
15 [.10-.22] 
10 [.07-.15] 
11 [.07-.17] 
8 [.04-.15] 
14 [.09-.21] 
Primary Insurance group (n=738) 
     Commercial/Private 
     Medicare/Medicaid 
 
639 (87) 
99 (13) 
 
11 [09-.14] 
13 [.07-.21] 
Delivery (n=754) 
     Vaginal 
     Cesarean section 
 
413 (55) 
341 (45) 
 
12 [.09-.16] 
11 [.08-.15] 
Shoulder dystocia (n=754) 
      Yes 
      No 
 
12 (2) 
752 (98) 
 
33 [.14-.61] 
11 [.09-.13]  
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Table 3. Factors associated with LGA/macrosomia by maternal demographics, 2010-2016.  
 Odds ratio 
(95% CI exp *) 
 
p-value 
 (<0.05) 
Maternal age  
     25 or under 
     26-30 
     31-36 
     37 or above 
 
referent 
.66 (.11-3.9) 
1.325 (.28-6.1) 
.48 (.06-3.8) 
 
 
 
.652 
.718 
.488 
Maternal race/ethnicity  
     Caucasian 
     African American 
     Hispanic 
     Other 
 
 
referent 
.06 (.01-.80)* 
.05 (.01-.75)* 
.93 (.09-9.1) 
 
 
 
.033* 
.030* 
.947 
 
Maternal BMI  
     Underweight 
     Normal 
     Overweight/Obese 
    
 
0 
referent 
.23 (.04-1.4) 
 
1.00 
 
.115 
Average Income Group  
     Less than $50,000 
     $50-55,000 
     $56-65,000 
     $66-75,000 
     $76,000 or greater  
 
 
1.7 (.34-8.9) 
referent 
.10 (.01-1.0) 
.42 (.08-2.2) 
1.2 (.26-5.6) 
 
 
.505 
 
.052 
.309 
.807 
Primary Insurance group  
     Commercial/Private 
     Medicare/Medicaid 
 
referent 
10.7 (1.7-68)*  
 
 
.011* 
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Discussion 
The analysis found that the rate of babies born LGA to women with gestational diabetes 
mellitus at Butterworth Hospital between 2010-2016 was similar to overall rates of macrosomia 
in the United States.3 One previous study investigating women with gestational diabetes, 
however, estimated that 15-45% of newborns born to these women were LGA, indicating that 
this study sample’s incidence rate of 11.8% is lower than the expected value.7 The wide range 
predicted by Kamana et. al could be attributed to various maternal and environmental factors, 
including adequacy of prenatal care as well as whether or not women controlled their gestational 
diabetes with diet, insulin, or not at all. Our findings that shoulder dystocia occurs significantly 
more often in the delivery of LGA babies is also supported by other studies.18  
Maternal characteristics including age, income level, race/ethnicity, and BMI have been 
associated with maternal and fetal outcomes of pregnancy. Although maternal body weight 
classifications of overweight/obesity have been previously linked to increased macrosomia risk, 
this was not supported by this study's findings. Our findings likely did not reach statistical 
significance due to the limited number of cases of macrosomia in women that had a pre-
pregnancy BMI entered into their electronic medical record.  
Prior to this study, few researchers had examined socioeconomic status's influence on 
risk for delivering a macrosomic baby. When average annual income was used as a proxy, no 
difference between groups was found, nor was there a significant odds ratio when all other 
categorical variables were considered. Even more, no significant difference in rates of LGA 
between women with commercial and government insurance was identified. On the contrary, 
when age, pre-pregnancy BMI, race/ethnicity, and annual income were considered together in a 
logistic regression model, the odds of delivering a LGA baby was 10.7 times greater for those 
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with Medicaid/Medicare. This finding supports the notion that mothers on government assisted 
health insurance experience worse perinatal outcomes as a result of Gestational diabetes mellitus.  
A similar trend was identified with race/ethnicity.  No difference was observed between 
women of Caucasian, African American, Hispanic, and Other groups when the individual effect 
was measured. Surprisingly, when this variable was measured with adjustment for all other 
maternal demographics, there was a decreased likelihood of African American and Hispanic 
women of having a large baby when compared to Caucasian women. Some research previously 
conducted has found that the odds of macrosomia among Caucasian women to be highest while 
others find the opposite. One reason for the ethnic variation in macrosomia rates may be due to a 
screening and diagnostic process that over detects glucose intolerance in certain racial/ethnic 
groups. The current method used to diagnose Gestational diabetes mellitus is two-fold, with a 
one-hour 50-gram glucose loading test (GLT) used as a screening tool first. If this value returns 
above a certain threshold, a three-hour 100-gram glucose tolerance test is completed, with 
diagnoses being made if two of the four values are high. Previous studies have suggested the 
need for race-specific thresholds after identifying that mean GLT values vary significantly by 
race. Nahum et. al found that Asian women had the highest mean GLT value (134.7 mg/dL) 
while African American women had the lowest (116.4 mg/dL).49 In another study by Esakoff et 
al., they demonstrated an optimal screening threshold of 135 mg/dL for African Americans, 140 
mg/dL for whites and Hispanics, and 145 mg/dL for Asians in order to achieve a 90% sensitivity 
and 10% false-positive rate.50    
In order to further investigate these findings, another logistic regression model was 
created using age, racial/ethnic group, average income group, cesarean section, and BMI to 
assess risk for being on Medicare/Medicaid in this patient population. Hispanic and African 
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American women were at a 11.5 and 13.5 times increased chance, respectively, of being 
beneficiaries of these forms of insurance. Due to the outcomes of this study, it is conceivable that 
an interaction is occurring between pre-pregnancy BMI and another variable. It is possible to 
distinguish pre-pregnancy BMI as one predictor because it had to be included in the logistic 
regression model in order for significance to be achieved.  
This study is not without limitations. One such limitation is the number of women whose 
BMI had been gathered prior to pregnancy. In addition, the time the mother’s weight and height 
had been taken varied and was not a perfect reflection of their BMI immediately prior to 
becoming pregnant. Even more, all of the BMI’s entered were for deliveries that took place 
between 2011-2014, with the majority taking place in 2014. It is also important to note that just 
12 women were of normal weight, while overweight/obese women accounted for 129 of the total 
count. This rather lopsided distribution could account for the insignificant confidence of 
proportions as previous studies have regularly found an increased proportion of macrosomic 
births with increased BMI. Because medical records with missing BMI values could not be 
included in the binary logistic regression, this decreased the viable sample size significantly from 
754 to 142. To reiterate, this cohort is a mere snapshot and is probably not generalizable to other 
urban areas. Another limitation is the aggregation of multiple ethnic groups into four larger 
groups due to small numbers. The Other group includes diverse groups of people such as Asian, 
European, and African women.  Finally, the retrospective study design depended on previously 
collected data for analysis and did not allow for any clarification of pre-existing data nor 
gathering of information surrounding lifestyle modification, glycemic control, medication usage, 
or gestational weight gain.  
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Conclusion 
Similar to previous estimates, the rate of macrosomia among women with Gestational 
diabetes mellitus was 11.8%. Additionally, shoulder dystocia took place more often in babies 
born Large-for-gestational age than those that were of normal or smaller size. Women with 
government funded health insurance were placed at an increased likelihood of having an LGA 
baby, while Hispanic and African American women were at a decreased likelihood. Future 
studies should further examine what maternal factors are related to pre-pregnancy BMI. In 
identifying the extent of confounding variables, the individual influence of features like 
socioeconomic status can be considered more confidently. Even more, the lack of pre-pregnancy 
BMI data illustrates a potential need for closer tracking of maternal weight and/or better 
dissemination between obstetrician-gynecologist (OBGYN) providers and the hospital. It is clear 
that social determinants of health are extensive and influence one another. As such, future studies 
should give wider consideration to variables like prenatal care adequacy, paternal race/ethnicity, 
social support, and WIC participation in order to shed a better light on the risk factors for 
macrosomia after GDM.   
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